Sunday - February 1, 2026
A&O Shearman Advises GSK on USD2.2 Billion Acquisition of RAPT Therapeutics
January 23, 2026
LONDON, England, Jan. 23 -- A and O Shearman, a law firm, issued the following news:

* * *

A&O Shearman advises GSK on USD2.2 billion acquisition of RAPT Therapeutics

A&O Shearman is advising GSK plc (LSE/NYSE: GSK) on its definitive agreement to acquire RAPT Therapeutics (NASDAQ: RAPT), a California-based, clinical-stage biopharmaceutical company, for an estimated equity value of USD2.2bn.

The acquisition includes ozureprubart, a pote . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products